[Vaccination Against COVID-19 in Patients Treated with Psychotropic Drugs]. / COVID-19-Impfung unter Psychopharmakotherapie.
Psychiatr Prax
; 48(8): 399-403, 2021 Nov.
Article
en De
| MEDLINE
| ID: mdl-34344044
Vaccines against SARS-CoV-2 have been available in the European Union since December 2020. Persons suffering from mental illness have an increased risk of a severe or fatal course following an infection with SARS-CoV-2. Thus, the question arises to what extent interactions between the newly approved vaccines and psychotropic drugs may be expected. Data on the tolerability and efficacy of vaccines against SARS-CoV-2 under treatment with psychotropic drugs are not available to date - however, potential interactions can be derived from previous investigations on vaccines against other pathogens, such as a reduced immune response with lower clinical efficacy and an increase in drug plasma levels due to the indirect vaccine-mediated inhibition of metabolizing enzymes. On the other hand, depressed patients treated with antidepressant medication show a better immune response.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
COVID-19
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
De
Revista:
Psychiatr Prax
Año:
2021
Tipo del documento:
Article
Pais de publicación:
Alemania